Evidence map›Paper›PMID 28127512›Full record

ArticleBrain and behavior2017

Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Edward J Modestino, Chioma Amenechi, AnnaMarie Reinhofer, Patrick O'Toole

Abstract read
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. A novel rat model of body first subtype of Parkinson's disease.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.Journal of the International Neuropsychological Society : JINS · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edward J ModestinoDepartment of Neurology Boston University School of Medicine Boston MA USA.
Chioma AmenechiDepartment of Neurology Boston University School of Medicine Boston MA USA.
AnnaMarie ReinhoferDepartment of Neurology Boston University School of Medicine Boston MA USA.
Patrick O'TooleDepartment of Neurology Boston University School of Medicine Boston MA USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) usually emerges with a unilateral side-of-onset (left-onset: LOPD; right-onset: ROPD; Marinus & van Hilten, 2015) due to an asymmetrical degeneration of striatal dopaminergic neurons (Donnemiller et al.,

methodsThirty ROPD and 14 LOPD cases were drawn from a Boston clinic specializing in PD. Various cognitive and neuropsychological measures were used in an attempt to discover if there were indeed any differences between LOPD and ROPD in this cohort.

resultsFor LOPD, duration of illness was found to be significantly greater than that of ROPD. However, further testing was able to confirm that despite this difference, it was not the cause of the other significant differences found. Furthermore, this increased duration was consistent with a previous study (Munhoz et al.,

conclusionClear and significant differences between LOPD and ROPD were found within our cohort. LOPD showed greater impairment of working memory, greater anxiety, and greater duration of illness-all independent of one another; whereas, those with ROPD had greater magical ideation, also independent of any other variables.

Indexed as

AdultAgedAged, 80 and overAnxietyCognitive DysfunctionCohort StudiesExecutive FunctionFemaleHumansMaleMemory, Short-TermMiddle AgedNeuropsychological TestsParkinson DiseasecognitiveneuropsychologyParkinson's diseaseSide‐of‐onset

Identifiers

PMID28127512
PMCPMC5256177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.